NCT00031941View on ClinicalTrials.gov

CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2002

Primary Completion Date

September 30, 2007

Study Completion Date

April 30, 2009

Conditions
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

lenalidomide

Trial Locations (2)

20892

NCI - Center for Cancer Research, Bethesda

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00031941 - CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy | Biotech Hunter | Biotech Hunter